Artificial Intelligence (AI) has made significant inroads across all sectors, and healthcare is no exception. In the field of spine surgery, AI is being increasingly integrated to support and enhance clinical decision-making and surgical precision. From preoperative planning, postoperative outcome prediction, and advanced imaging analysis to the management of large-scale datasets, AI is helping to improve patient outcomes while also aiming to reduce the overall cost of care.
The stock we are bringing to your attention today is that of Carlsmed Inc. (CARL), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com